In the 90 days previous to the date of this filing, there have been 10 insider transactions reported to the SEC for Veracyte. These transactions came from the activities of 5 individual insiders that resulted in a net acquisition of 63,576 company shares. This compares with the preceding 90-day window of time where there were 26 transactions from 6 insiders which resulted in the net disposition of 1,026,707 shares.
This level of insider transactions is lower than the peer group average in the 10-company Bio Diagnostics & Testing peer group over the last 90-day period. Activity in the peer group averaged 35.5 transactions per company, with company insiders acquiring on average 238,215 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1384101/000138410119000104/xslF345X03/wf-form4_156564147451154.xml
|Consensus Estimates for Zynex's Q4, 2019, 2020 Years...|
|Alleghany's 2020, and Q1 Estimates Lowered but 2021 ...|
|Zscaler's 2021 Earnings Estimate Cut|
|Wynn Resorts' Consensus Forecasts for Q1, 2020, and ...|
|Cimarex Energy's 2020, 2021, and Q1 Earnings Estimat...|